Skip to main content
  1. aggrego News
  2. Multiple Myeloma

Adaptation to Bortezomib Treatment in Multiple Myeloma Cells

Recommended
Adaptation to Bortezomib Treatment in Multiple Myeloma Cells
Proposed Second Revision of the International Staging System for Survival in Multiple Myeloma
Extracellular Vesicle Proteomic Analysis Leads to the Discovery of HDGF as a New Factor in Multiple Myeloma Biology
Using a Transcriptomic Profile to Identify Plasma Cell Leukemia–Like Disease in Patients With Newly Diagnosed Multiple Myeloma
Aggrego Oncology - 5/19/22
Racial Disparities Seen in US Food and Drug Administration Drug Approval Trials in Multiple Myeloma
Clinical Outcomes of BCMA CAR-T Cells in a Multiple Myeloma Patient With Central Nervous System Invasion
Bispecific Antibodies With Multiple Targets Moving Forward in Multiple Myeloma

Adaptation to Bortezomib Treatment in Multiple Myeloma Cells

header-info
Jun. 20, 2022
social-elements

Researchers characterized possible features of multiple myeloma (MM) cells that may be related to bortezomib (BTZ) resistance in patients with MM, in a new study published in the journal Cell Death and Disease.

Footer branding


Footer main navigation

  • About Us
  • Contact Us
  • Privacy Policy
  • Sign in

HMP Global Products

  • HMP Global Learning Network
  • Consultant360
  • VRTX

Copyright branding

© 2022 HMP Global. Aggrego is a trademark of HMP Global. All Rights Reserved.

<!-- BEGIN ADVERTSERVE CODE -->
<div id="mobile_block_ad_1"><script type="text/javascript">
var _avp = _avp || [];
_avp.push({ tagid: 'mobile_block_ad_1', alias: '/', type: 'banner', zid: 1669, pid: 0, onscroll: 0, inview: true, secure: true });
</script></div>
<!-- END ADVERTSERVE CODE -->

Home

Site branding - mobile

Upper navigation

  • Today
    Today
  • Following
    Following
  • Specialties
    Specialties

Main navigation

  • News
    news
  • TV
    TV
  • Radio
    Radio
  • Conference Hub
    Conf hub

User imageSign in

Register

Additional navigation- 1

  • Acute Basal Cell Carcinoma
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • AML+CLL
  • Breast Cancer
  • CAR-T Cell Therapy
  • Chronic ITP
  • Chronic Lymphocytic Leukemia
  • Colorectal Cancer
  • Cutaneous Squamous-Cell Carcinoma
  • Diffuse Large B-Cell Lymphoma
  • Early Breast Cancer
  • FDA Approvals
  • Febrile Neutropenia
  • Follicular Lymphoma
  • Gastrointestinal Cancer
  • Genitourinary Cancer
  • Graft Versus Host Disease
  • Gynecologic Cancer
  • Head And Neck Cancer
  • Healthcare Policy
  • Hematologic Malignancies
  • HER2 Low mBC
  • Immuno Oncology

Additional navigation- 2

  • Liver Cancer
  • Lung Cancer
  • Marginal Zone Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myelofibrosis
  • Non-Small-Cell Lung Cancer
  • Oncology Nursing
  • Ovarian Cancer
  • Pancreatic Cancer
  • Pediatric Oncology
  • Prostate Cancer
  • Radiation Oncology
  • Renal Cell Carcinoma
  • RET+ Advanced Thyroid Cancer
  • RET+ NSCLC
  • Sarcoma
  • Skin Cancer
  • Solid Tumors
  • Supportive Care
  • Surgical Cancer
  • Urethral Carcinoma